LY75/DEC-205 Protein (AA 28-1666) (His tag)
-
- Antigène Voir toutes LY75/DEC-205 (LY75) Protéines
- LY75/DEC-205 (LY75) (Lymphocyte Antigen 75 (LY75))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 28-1666
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette LY75/DEC-205 protéine est marqué à la His tag.
- Fonction
- Human LY75 / CD205 Protein, His Tag
- Pureté
- >90 % as determined by SDS-PAGE.
- niveau d'endotoxine
- Less than 1.0 EU per μg by the LAL method.
- Top Product
- Discover our top product LY75 Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4
- Stock
- -20 °C
-
- Antigène
- LY75/DEC-205 (LY75) (Lymphocyte Antigen 75 (LY75))
- Autre désignation
- LY75 (LY75 Produits)
- Synonymes
- LY75 Protein, MGC140308 Protein, DEC205 Protein, im:7150926 Protein, si:dkey-78p20.2 Protein, LYT75 Protein, CD205 Protein, DEC-205 Protein, CLEC13B Protein, GP200-MR6 Protein, LY-75 Protein, RGD1565962 Protein, Ly-75 Protein, lymphocyte antigen 75 Protein, CD205 protein Protein, CD302 antigen Protein, LY75 Protein, Cyan7822_2917 Protein, LY5 Protein, ly75 Protein, cd205 Protein, LOC100380704 Protein, LOC100433861 Protein, LOC100483541 Protein, Ly75 Protein
- Sujet
- Lymphocyte antigen 75 (Ly 75, also known as CD205, CLEC13B, GP200-MR6 and DEC-205, is a type I transmembrane protein that is primarily expressed on dendritic cells and thymic epithelial cells. LY75 functions as an endocytic receptor for antigens. MEN1309/OBT076, the first antibody drug targeting CD205, has shown strong preclinical anti-tumor activity in lymphoma. After being verified as a single drug in vivo, the antibody-drug conjugate has a synergistic effect with the BCL2 inhibitor Venetoclax and the anti-cd20 monoclonal antibody rituximab.
- Poids moléculaire
- 190.7 kDa
- NCBI Accession
- NP_002340
-